US FDA

Sun Pharma gets US FDA nod for generic lenalidomide capsules

Read more

Lupin gets US FDA approval for Brivaracetam Tablets

Read more

US FDA declines to approve Y-mAbs’s paediatric cancer drug

Read more

Provention Bio diabetes drug to cost $13,850/vial

Read more

Eugia Pharma receives US FDA nod for Amphotericin B Liposome Injection

Read more

US FDA issues warning letter to Lupin for Maharashtra-based API plant

Read more

US FDA extends review of Amicus muscle disorder therapy for second time

Read more

Three pharma companies recall products in US

Read more

US FDA issues four observations to Alembic Pharma’s Panelav plant

Read more

US health regulator extends review of Biogen’s ALS drug

Read more